Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers
Rationale There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated...
Saved in:
| Published in | Psychopharmacology Vol. 232; no. 10; pp. 1793 - 1801 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2015
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Rationale
There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported.
Objectives
The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers.
Methods
Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information.
Results
The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS.
Conclusion
The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. |
|---|---|
| AbstractList | There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported.RATIONALEThere is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported.The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers.OBJECTIVESThe present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers.Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information.METHODSForty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information.The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS.RESULTSThe salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS.The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders.CONCLUSIONThe suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. Rationale: There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. Objectives: The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. Methods: Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno registered -galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information. Results: The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. Conclusion: The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibers that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerized task battery assessing the processing of emotionally salient information. The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information. The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. Rationale There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. Objectives The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. Methods Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information. Results The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. Conclusion The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information. The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. Rationale There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information that is strongly linked to anxiety and depression, and influences the neuroendocrine stress response. We have recently demonstrated that prebiotics (soluble fibres that augment the growth of indigenous microbiota) have significant neurobiological effects in rats, but their action in humans has not been reported. Objectives The present study explored the effects of two prebiotics on the secretion of the stress hormone, cortisol and emotional processing in healthy volunteers. Methods Forty-five healthy volunteers received one of two prebiotics (fructooligosaccharides, FOS, or Bimuno®-galactooligosaccharides, B-GOS) or a placebo (maltodextrin) daily for 3 weeks. The salivary cortisol awakening response was sampled before and after prebiotic/placebo administration. On the final day of treatment, participants completed a computerised task battery assessing the processing of emotionally salient information. Results The salivary cortisol awakening response was significantly lower after B-GOS intake compared with placebo. Participants also showed decreased attentional vigilance to negative versus positive information in a dot-probe task after B-GOS compared to placebo intake. No effects were found after the administration of FOS. Conclusion The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. Further studies are therefore needed to test the utility of B-GOS supplementation in the treatment of stress-related disorders. |
| Audience | Academic |
| Author | Schmidt, Kristin Cowen, Philip J. Errington, Steven Tzortzis, George Harmer, Catherine J. Burnet, Philip W. J. |
| Author_xml | – sequence: 1 givenname: Kristin surname: Schmidt fullname: Schmidt, Kristin organization: Department of Psychiatry, University of Oxford, Warneford Hospital – sequence: 2 givenname: Philip J. surname: Cowen fullname: Cowen, Philip J. organization: Department of Psychiatry, University of Oxford, Warneford Hospital – sequence: 3 givenname: Catherine J. surname: Harmer fullname: Harmer, Catherine J. organization: Department of Psychiatry, University of Oxford, Warneford Hospital – sequence: 4 givenname: George surname: Tzortzis fullname: Tzortzis, George organization: Clasado Research Services Ltd – sequence: 5 givenname: Steven surname: Errington fullname: Errington, Steven organization: Institute for Ageing and Health, Newcastle University – sequence: 6 givenname: Philip W. J. surname: Burnet fullname: Burnet, Philip W. J. email: phil.burnet@psych.ox.ac.uk organization: Department of Psychiatry, University of Oxford, Warneford Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25449699$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl1rFDEYhYNU7Hb1B3gjA954M_XN5GMmN0IpfkFBL_Q6ZJJ3dtPOJmsy09J_b9ZtZVtUTC4CeZ9zCCfnhByFGJCQlxROKUD7NgM0lNVAec06CjU8IQvKWVM30DZHZAHAWM2o6I7JSc6XUBbv-DNy3AjOlVRqQfBrwt7HydvKh8lcYZXQzRZzNa2xujFXPqwqG9PkcxzLLG9jyFiZ4CozTphyhZuijsGMVe9NLi7VGstofVtdx3EOExboOXk6mDHji7tzSb5_eP_t_FN98eXj5_Ozi9q2IKe6F9hzyyVH7qxD41rXDyBB2Q5QdL3qeiuUw0ZIKwcFzA6DFbLpqFLO0Z4tybu973buN-gshimZUW-T35h0q6Px-uEk-LVexWvNOQXKZDF4c2eQ4o8Z86Q3PlscRxMwzllT2QFnUrbdf6CtFEoKoQr6-hF6GedUIvtFiY5R4AfUyoyofRhieaLdmeozzjhvRFt-e0lO_0CV7XDjbenH4Mv9A8Grw0x-h3HfgQK0e8CmmHPCQVs_md2fFmc_agp61za9b5subdO7tmkoSvpIeW_-L02z1-TChhWmgyz-KvoJREfm4Q |
| CitedBy_id | crossref_primary_10_1097_FBP_0000000000000478 crossref_primary_10_3389_fendo_2023_1335202 crossref_primary_10_1016_j_psychres_2015_04_023 crossref_primary_10_3390_challe8020024 crossref_primary_10_1177_1745691618809379 crossref_primary_10_1017_neu_2017_3 crossref_primary_10_3390_microorganisms10091687 crossref_primary_10_1016_j_bbr_2020_112718 crossref_primary_10_3389_fphar_2021_712531 crossref_primary_10_3390_nu16162578 crossref_primary_10_3390_nu13103533 crossref_primary_10_1007_s00213_019_05248_6 crossref_primary_10_1016_j_neuropharm_2019_107909 crossref_primary_10_1016_j_bbi_2017_08_026 crossref_primary_10_1186_s43045_024_00395_9 crossref_primary_10_1016_j_ynstr_2016_03_001 crossref_primary_10_3923_tasr_2019_70_79 crossref_primary_10_1016_j_euroneuro_2020_03_006 crossref_primary_10_1080_1028415X_2018_1493808 crossref_primary_10_1016_j_jinf_2016_09_010 crossref_primary_10_1097_PSY_0000000000000519 crossref_primary_10_1021_acs_jafc_5b02404 crossref_primary_10_1097_j_pain_0000000000000779 crossref_primary_10_1007_s00394_016_1213_1 crossref_primary_10_1016_j_ifset_2024_103667 crossref_primary_10_3390_foods8030092 crossref_primary_10_1002_jnr_24616 crossref_primary_10_1007_s15202_017_1661_3 crossref_primary_10_3389_fnins_2017_00490 crossref_primary_10_1016_j_clnu_2018_11_010 crossref_primary_10_1017_S0140525X18002856 crossref_primary_10_1016_j_tics_2018_04_006 crossref_primary_10_1111_cns_14091 crossref_primary_10_3389_fnut_2025_1551313 crossref_primary_10_1007_s00281_025_01036_x crossref_primary_10_1007_s12160_015_9753_9 crossref_primary_10_1016_j_xcrm_2025_101982 crossref_primary_10_1016_j_neubiorev_2024_105722 crossref_primary_10_1111_nyas_13416 crossref_primary_10_3390_nu14132641 crossref_primary_10_1016_j_cyto_2021_155590 crossref_primary_10_1016_j_euroneuro_2017_11_001 crossref_primary_10_1016_j_yfrne_2018_04_002 crossref_primary_10_5812_archneurosci_60507 crossref_primary_10_3390_nu14030614 crossref_primary_10_1016_j_lwt_2018_05_056 crossref_primary_10_3390_gidisord6040056 crossref_primary_10_3389_fnut_2023_1173660 crossref_primary_10_1016_j_gtc_2016_09_007 crossref_primary_10_3389_fnins_2020_00770 crossref_primary_10_1016_j_jff_2020_104176 crossref_primary_10_1002_cpt_2581 crossref_primary_10_1186_s12967_017_1236_2 crossref_primary_10_3920_BM2016_0222 crossref_primary_10_3390_biomed3040035 crossref_primary_10_1155_2022_6508046 crossref_primary_10_3390_cimb45030168 crossref_primary_10_3390_nu15092041 crossref_primary_10_1007_s10803_024_06239_z crossref_primary_10_21307_PM_2020_59_1_001 crossref_primary_10_3389_fphys_2018_00184 crossref_primary_10_1097_NT_0000000000000481 crossref_primary_10_3390_cells10082084 crossref_primary_10_1016_j_bbi_2019_05_024 crossref_primary_10_3389_fnins_2022_1097278 crossref_primary_10_1007_s40139_018_0160_3 crossref_primary_10_1016_j_bbi_2019_07_019 crossref_primary_10_1136_bmjos_2018_000017 crossref_primary_10_1080_10408398_2021_1879004 crossref_primary_10_1007_s00213_020_05665_y crossref_primary_10_2174_0113892010281892240116081031 crossref_primary_10_4103_jpbs_JPBS_47_19 crossref_primary_10_3389_fendo_2023_1130689 crossref_primary_10_1038_s41598_021_87865_w crossref_primary_10_3390_microorganisms13010185 crossref_primary_10_1093_nutrit_nuy052 crossref_primary_10_3389_fpsyt_2024_1423715 crossref_primary_10_1016_j_bbi_2017_08_017 crossref_primary_10_3389_fpsyt_2019_00784 crossref_primary_10_3390_ijms24054477 crossref_primary_10_1080_13803395_2015_1121969 crossref_primary_10_4081_cp_2017_987 crossref_primary_10_2174_1570159X21666230322145049 crossref_primary_10_1007_s40473_018_0138_9 crossref_primary_10_1016_j_psyneuen_2018_05_027 crossref_primary_10_1016_j_bbi_2021_01_014 crossref_primary_10_1146_annurev_neuro_072116_031347 crossref_primary_10_1017_S0007114516002269 crossref_primary_10_1155_2016_2718275 crossref_primary_10_37349_emed_2022_00097 crossref_primary_10_1007_s00213_019_05230_2 crossref_primary_10_1667_RR15493_1 crossref_primary_10_1007_s10571_021_01130_2 crossref_primary_10_3389_fpsyt_2021_565583 crossref_primary_10_3390_microorganisms10112141 crossref_primary_10_1002_jsf2_92 crossref_primary_10_1016_j_rgmxen_2021_02_002 crossref_primary_10_1002_mnfr_202200566 crossref_primary_10_1038_s41386_020_0732_x crossref_primary_10_1038_s41398_021_01422_7 crossref_primary_10_1016_j_foodchem_2024_140103 crossref_primary_10_3390_foods12132480 crossref_primary_10_3390_nu12051281 crossref_primary_10_1016_j_bbr_2018_12_047 crossref_primary_10_1124_dmd_115_063826 crossref_primary_10_3390_applmicrobiol4020049 crossref_primary_10_3390_nu15143122 crossref_primary_10_25259_SNI_72_2021 crossref_primary_10_3390_ph16040565 crossref_primary_10_1007_s13311_017_0600_5 crossref_primary_10_1002_phar_1640 crossref_primary_10_1016_j_neubiorev_2020_12_026 crossref_primary_10_1093_nutrit_nuz080 crossref_primary_10_1155_2020_6687358 crossref_primary_10_1177_0269881120908904 crossref_primary_10_1111_bph_14127 crossref_primary_10_31083_j_jin2203065 crossref_primary_10_3390_healthcare11152183 crossref_primary_10_1038_npp_2016_103 crossref_primary_10_1111_ijfs_15745 crossref_primary_10_1016_j_physbeh_2018_03_026 crossref_primary_10_3390_jdad1010003 crossref_primary_10_3390_nu12092669 crossref_primary_10_1080_24750573_2019_1625587 crossref_primary_10_1089_cap_2019_0072 crossref_primary_10_1016_j_imr_2020_100424 crossref_primary_10_3390_healthcare9050494 crossref_primary_10_3389_fphar_2018_01040 crossref_primary_10_3390_microorganisms6020035 crossref_primary_10_1016_j_neubiorev_2017_09_016 crossref_primary_10_1038_s41398_022_01977_z crossref_primary_10_3390_nu8090523 crossref_primary_10_1080_19490976_2019_1638722 crossref_primary_10_2527_jas_2016_1256 crossref_primary_10_3389_fpsyt_2021_648475 crossref_primary_10_1007_s13668_024_00520_4 crossref_primary_10_1016_j_tjnut_2023_02_015 crossref_primary_10_1038_s41598_023_29663_0 crossref_primary_10_18593_eba_27168 crossref_primary_10_1016_j_phrs_2021_105840 crossref_primary_10_1152_physrev_00018_2018 crossref_primary_10_1016_j_jad_2025_01_153 crossref_primary_10_3390_biomedicines9020189 crossref_primary_10_1515_revneuro_2021_0173 crossref_primary_10_1146_annurev_psych_122216_011613 crossref_primary_10_12677_acm_2024_1451474 crossref_primary_10_1017_gmb_2024_8 crossref_primary_10_3945_jn_116_233858 crossref_primary_10_1093_gastro_goab046 crossref_primary_10_3390_cells11182922 crossref_primary_10_1016_j_neuroscience_2022_04_026 crossref_primary_10_1093_advances_nmaa016 crossref_primary_10_1177_0706743719874168 crossref_primary_10_3390_ijms19061592 crossref_primary_10_1080_1028415X_2019_1701220 crossref_primary_10_3390_nu15081880 crossref_primary_10_1002_syn_21880 crossref_primary_10_1016_j_biopsych_2016_12_031 crossref_primary_10_1016_j_humic_2019_100069 crossref_primary_10_1016_j_phrs_2024_107559 crossref_primary_10_1016_j_biopsych_2017_08_014 crossref_primary_10_1021_acsbiomaterials_2c00774 crossref_primary_10_1177_1535370221995785 crossref_primary_10_3389_fnbeh_2016_00240 crossref_primary_10_17116_jnevro202312311133 crossref_primary_10_12677_OJNS_2023_113040 crossref_primary_10_3390_ijms23116097 crossref_primary_10_1111_jhn_12675 crossref_primary_10_1093_advances_nmaa181 crossref_primary_10_3389_fpsyt_2021_757139 crossref_primary_10_1007_s00415_019_09320_1 crossref_primary_10_1007_s40519_020_00983_8 crossref_primary_10_1016_j_ynstr_2017_03_001 crossref_primary_10_1371_journal_pone_0170208 crossref_primary_10_1111_brv_12603 crossref_primary_10_1016_j_jff_2021_104753 crossref_primary_10_1016_j_pnpbp_2020_109951 crossref_primary_10_3389_fpsyt_2024_1517508 crossref_primary_10_4236_fns_2017_82019 crossref_primary_10_1016_j_jep_2020_113608 crossref_primary_10_3390_nu11040890 crossref_primary_10_1038_s42255_024_01108_6 crossref_primary_10_1016_j_neubiorev_2020_07_036 crossref_primary_10_1016_j_tifs_2016_05_001 crossref_primary_10_1007_s13311_017_0585_0 crossref_primary_10_1016_j_jpsychires_2016_07_019 crossref_primary_10_1016_j_neuroscience_2015_09_068 crossref_primary_10_1016_j_lfs_2017_12_027 crossref_primary_10_1017_gmb_2021_3 crossref_primary_10_3390_microorganisms10040705 crossref_primary_10_12968_hmed_2019_80_3_139 crossref_primary_10_1016_j_neuropharm_2016_07_002 crossref_primary_10_1007_s00018_021_04060_w crossref_primary_10_1016_j_bbi_2015_10_007 crossref_primary_10_1134_S0022093021040013 crossref_primary_10_1080_10408398_2022_2137776 crossref_primary_10_3390_nu13010199 crossref_primary_10_1016_j_ebiom_2023_104442 crossref_primary_10_1093_nutrit_nuad143 crossref_primary_10_1007_s00787_017_0945_7 crossref_primary_10_1016_j_pnpbp_2020_110051 crossref_primary_10_3389_fnut_2022_896154 crossref_primary_10_1024_1422_4917_a000917 crossref_primary_10_1080_19420889_2024_2446332 crossref_primary_10_1093_femsec_fiw233 crossref_primary_10_1093_icb_icab118 crossref_primary_10_54296_18186173_2024_3_17 crossref_primary_10_1016_j_coph_2016_06_001 crossref_primary_10_1016_j_eng_2019_07_026 crossref_primary_10_3389_fpsyt_2021_587468 crossref_primary_10_1016_j_biopha_2023_114525 crossref_primary_10_3390_ijms22073723 crossref_primary_10_1080_10408398_2022_2053060 crossref_primary_10_1016_j_psyneuen_2020_105046 crossref_primary_10_1080_01639625_2017_1410373 crossref_primary_10_1016_j_advnut_2024_100343 crossref_primary_10_3390_ijms21114159 crossref_primary_10_1016_j_tins_2016_09_002 crossref_primary_10_1080_10408398_2021_1920884 crossref_primary_10_1016_j_bbr_2022_114081 crossref_primary_10_3390_ijms23147820 crossref_primary_10_3390_nu16142228 crossref_primary_10_1038_tp_2016_191 crossref_primary_10_1039_D4FO02221A crossref_primary_10_1002_dev_21821 crossref_primary_10_1016_j_neubiorev_2019_03_023 crossref_primary_10_3390_nu16172891 crossref_primary_10_1016_j_drudis_2023_103552 crossref_primary_10_4103_ijn_IJN_341_19 crossref_primary_10_1016_j_foodres_2019_108744 crossref_primary_10_1007_s40263_016_0370_3 crossref_primary_10_1016_j_ajcnut_2023_08_016 crossref_primary_10_1016_j_jmb_2016_02_018 crossref_primary_10_1016_j_rgmx_2021_02_004 crossref_primary_10_3390_foods11050759 crossref_primary_10_31793_1680_1466_2021_26_2_152 crossref_primary_10_1016_j_bbih_2024_100918 crossref_primary_10_1080_1028415X_2021_1975877 crossref_primary_10_1080_87559129_2025_2479123 crossref_primary_10_1016_j_cgh_2018_10_002 crossref_primary_10_1097_FBP_0000000000000538 crossref_primary_10_1186_s40246_021_00354_z crossref_primary_10_1002_tre_857 crossref_primary_10_1016_j_jad_2022_02_024 crossref_primary_10_1007_s00394_024_03546_0 crossref_primary_10_1111_ajad_13210 crossref_primary_10_1002_dev_21775 crossref_primary_10_1016_j_bbi_2017_03_002 crossref_primary_10_1016_j_schres_2019_03_003 crossref_primary_10_3390_nu11030521 crossref_primary_10_1097_MOG_0000000000000244 crossref_primary_10_3390_nu11071468 crossref_primary_10_3390_nu12072131 crossref_primary_10_3390_psychiatryint1020014 crossref_primary_10_3390_sports6030070 crossref_primary_10_1158_0008_5472_CAN_16_2929 crossref_primary_10_3390_ijms22147671 crossref_primary_10_3390_nu12103009 crossref_primary_10_3389_fncel_2015_00392 crossref_primary_10_1016_j_neubiorev_2019_12_011 crossref_primary_10_3390_app10051828 crossref_primary_10_1186_s12866_024_03435_w crossref_primary_10_1016_j_annepidem_2016_02_008 crossref_primary_10_1016_j_ynstr_2023_100572 crossref_primary_10_1038_s41380_020_00970_6 crossref_primary_10_5937_MedIst1803014Q crossref_primary_10_1016_j_heliyon_2024_e34092 crossref_primary_10_3389_fnins_2022_1048565 crossref_primary_10_2174_1570159X21666230222092029 crossref_primary_10_3390_nu13051534 crossref_primary_10_1080_09637486_2018_1462309 crossref_primary_10_3390_nu13030811 crossref_primary_10_1016_j_bbi_2016_11_018 crossref_primary_10_1016_j_neubiorev_2018_09_002 crossref_primary_10_3389_fnut_2023_1206468 crossref_primary_10_3390_cells11081362 crossref_primary_10_5604_01_3001_0014_3416 crossref_primary_10_3390_nu15245037 crossref_primary_10_1016_j_arr_2020_101079 crossref_primary_10_1080_1028415X_2024_2425570 crossref_primary_10_3390_nu9111247 crossref_primary_10_3390_nu12123644 crossref_primary_10_1007_s10068_024_01620_1 crossref_primary_10_1016_j_cobeha_2022_101101 crossref_primary_10_3390_antiox10111845 crossref_primary_10_1016_j_fbio_2024_103831 crossref_primary_10_3920_BM2021_0122 crossref_primary_10_1111_nmo_13440 crossref_primary_10_1017_S0007114524002186 crossref_primary_10_1016_j_ynstr_2024_100629 crossref_primary_10_1007_s13668_019_0265_2 crossref_primary_10_2174_1381612826666200122153541 crossref_primary_10_1080_10408398_2018_1484340 crossref_primary_10_3390_medsci7020021 crossref_primary_10_1002_brb3_1408 crossref_primary_10_1016_j_pranut_2018_03_007 crossref_primary_10_1016_j_psym_2017_02_004 crossref_primary_10_1016_j_lpm_2015_10_016 crossref_primary_10_1016_j_pbb_2023_173561 crossref_primary_10_1080_10408398_2022_2164244 crossref_primary_10_1002_cncr_31584 crossref_primary_10_1016_j_physbeh_2022_113900 crossref_primary_10_1155_2021_5554363 crossref_primary_10_1155_2024_2856759 crossref_primary_10_1146_annurev_clinpsy_050718_095432 crossref_primary_10_1007_s00394_018_1703_4 crossref_primary_10_1038_s41390_018_0211_9 crossref_primary_10_1093_nutrit_nuy009 crossref_primary_10_1177_2515690X20957225 crossref_primary_10_12938_bmfh_19_006 crossref_primary_10_1111_jpn_13972 crossref_primary_10_1038_s41392_023_01673_4 crossref_primary_10_1038_s41598_024_57649_z crossref_primary_10_3390_nu12071920 crossref_primary_10_3390_ijerph17051493 crossref_primary_10_1016_j_bbi_2020_02_004 crossref_primary_10_1146_annurev_pharmtox_010919_023628 crossref_primary_10_1097_YCO_0000000000000350 crossref_primary_10_1038_nrgastro_2017_75 crossref_primary_10_3389_fmed_2022_813204 crossref_primary_10_1017_S003329172100550X crossref_primary_10_3390_nu13072204 crossref_primary_10_1038_mp_2016_50 crossref_primary_10_3390_nu13124384 crossref_primary_10_3390_ijms252313208 crossref_primary_10_1021_acs_jafc_8b07313 crossref_primary_10_1016_j_trsl_2016_10_002 crossref_primary_10_1177_0269881119862534 |
| Cites_doi | 10.1002/bies.201100024 10.1037/0022-3514.54.6.1063 10.1002/da.20680 10.1176/appi.ajp.2008.08050721 10.1016/S0005-7967(96)00069-1 10.1007/s00018-012-1028-z 10.1080/14640749408401099 10.1053/j.gastro.2013.02.043 10.1192/bjp.bp.108.056093 10.1037/a0021148 10.1016/j.psyneuen.2012.03.007 10.1017/S0033291707000669 10.1016/j.psyneuen.2010.12.006 10.1136/gut.2006.117176 10.2307/2136404 10.1017/S0033291712000591 10.1111/j.1552-6909.2006.00051.x 10.1016/S0024-3205(97)01008-4 10.1038/nrgastro.2009.35 10.1038/npp.2010.166 10.1038/ajg.2009.25 10.1016/j.psyneuen.2012.03.024 10.1016/j.cpr.2009.11.003 10.1038/sj.npp.1300004 10.1016/S0006-3223(01)01263-X 10.1016/j.neuint.2013.10.006 10.1037/h0025907 10.1080/026999398379411 10.3758/CABN.10.1.8 10.1017/S0007114510004319 10.1016/S0005-7967(98)00063-1 10.1038/npp.2010.77 10.1016/j.tins.2008.06.006 10.1038/nrn3346 10.1111/j.1365-2982.2010.01664.x 10.1038/nrgastro.2010.117 10.1016/j.neubiorev.2011.07.001 10.1016/j.brat.2004.08.004 10.1176/ajp.2007.164.4.617 10.1186/1757-4749-1-6 10.1192/bjp.bp.108.051193 10.1016/j.brat.2003.08.001 10.1016/j.psyneuen.2014.01.014 10.1073/pnas.1102999108 10.1038/nrn3071 10.1053/j.gastro.2005.11.033 10.1001/archpsyc.61.9.877 10.1113/jphysiol.2004.063388 10.1016/j.coph.2012.09.010 10.1176/appi.ajp.161.7.1256 10.1177/0269881106074062 10.1016/S0306-4530(03)00072-6 10.3109/10242422.2013.828048 10.1111/j.2044-8341.1974.tb02285.x 10.1001/archpsyc.1961.01710120031004 10.1038/nrn2555 10.3945/ajcn.2008.26242 10.1016/S0010-0277(97)00003-6 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2014 COPYRIGHT 2015 Springer Springer-Verlag Berlin Heidelberg 2015 |
| Copyright_xml | – notice: The Author(s) 2014 – notice: COPYRIGHT 2015 Springer – notice: Springer-Verlag Berlin Heidelberg 2015 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
| DOI | 10.1007/s00213-014-3810-0 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Neurosciences Abstracts ProQuest One Psychology MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1432-2072 |
| EndPage | 1801 |
| ExternalDocumentID | PMC4410136 3666108761 A434425721 25449699 10_1007_s00213_014_3810_0 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom |
| GeographicLocations_xml | – name: United Kingdom |
| GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council – fundername: Wellcome Trust – fundername: Medical Research Council |
| GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS C6C KOW N2Q R9- RHV SBY SOJ X7M ~EX AAYXX CITATION --- -Y2 .86 .GJ .VR 04C 06C 06D 0R~ 0VY 123 199 1N0 1SB 2.D 203 28- 29P 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2QV 2VQ 2~H 30V 36B 3O- 4.4 406 408 409 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDBF ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPIV ACPRK ACSTC ACUHS ACZOJ ADBBV ADHHG ADHIR ADHKG ADIMF ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFFNX AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. B0M BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 DWQXO DXH EAD EAP EBC EBD EBLON EBS ECM EIF EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPAXT EPL EPS ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICJ IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M2M M4Y MA- MK0 N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF- PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TN5 TSG TSK TSV TUC TUS U2A U9L UAP UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WIP WJK WK6 WK8 WOW XOL YLTOR YQJ YYP Z45 ZGI ZMTXR ZOVNA ZY4 ~8M 3V. 7QG 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c706t-b5eb4c464e4dcdead7dbf0609c80e58b98bc59de256c6f903cffc5628199dd1b3 |
| IEDL.DBID | 7X7 |
| ISSN | 0033-3158 1432-2072 |
| IngestDate | Thu Aug 21 13:51:09 EDT 2025 Fri Jul 11 04:19:37 EDT 2025 Fri Jul 11 02:44:26 EDT 2025 Sat Aug 16 02:51:30 EDT 2025 Wed Mar 19 01:03:07 EDT 2025 Sat Mar 08 18:42:52 EST 2025 Mon Jul 21 06:00:03 EDT 2025 Thu Apr 24 23:08:41 EDT 2025 Tue Jul 01 04:16:46 EDT 2025 Fri Feb 21 02:34:09 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | Gut microbiota Emotional processing Attention Hypothalamic-pituitary-adrenal axis Cortisol Anxiety Prebiotics |
| Language | English |
| License | Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c706t-b5eb4c464e4dcdead7dbf0609c80e58b98bc59de256c6f903cffc5628199dd1b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doi.org/10.1007/s00213-014-3810-0 |
| PMID | 25449699 |
| PQID | 1675831049 |
| PQPubID | 47309 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4410136 proquest_miscellaneous_1680436678 proquest_miscellaneous_1676596559 proquest_journals_1675831049 gale_infotracmisc_A434425721 gale_infotracacademiconefile_A434425721 pubmed_primary_25449699 crossref_citationtrail_10_1007_s00213_014_3810_0 crossref_primary_10_1007_s00213_014_3810_0 springer_journals_10_1007_s00213_014_3810_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-05-01 |
| PublicationDateYYYYMMDD | 2015-05-01 |
| PublicationDate_xml | – month: 05 year: 2015 text: 2015-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Psychopharmacology |
| PublicationTitleAbbrev | Psychopharmacology |
| PublicationTitleAlternate | Psychopharmacology (Berl) |
| PublicationYear | 2015 |
| Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
| References | Harmer (CR34) 2010; 27 Murphy, Yiend, Lester (CR49) 2009; 12 Kunz-Ebrecht, Kirschbaum, Marmot, Steptoe (CR41) 2004; 29 Beck, Clark (CR5) 1997; 35 Sheline, Barch, Donnelly (CR58) 2001; 50 Spielberger, Gorsuch, Lushene (CR59) 1970 Cryan, Dinan (CR20) 2012; 13 Dinan, Cryan (CR22) 2012; 37 Savignac, Corona, Mills (CR56) 2013; 63 Gareau, Sherman, Walker (CR32) 2010; 7 Pizzagalli (CR52) 2010; 36 Cohen, Kamarck, Mermelstein (CR17) 1983; 24 Fu, Williams, Cleare (CR30) 2004; 61 Rhee, Pothoulakis, Mayer (CR55) 2009; 6 Tillisch, Labus, Kilpatrick (CR61) 2013; 144 Ait-Belgnaoui, Durand, Cartier (CR2) 2012; 37 Elliott, Zahn, Deakin, Anderson (CR25) 2011; 36 Pruessner, Wolf, Hellhammer (CR53) 1997; 61 Craig (CR18) 2009; 10 Murphy, Norbury, O’Sullivan (CR48) 2009; 194 Cisler, Koster (CR16) 2010; 30 Gareau, Jury, MacQueen (CR31) 2007; 56 Beck (CR4) 2008; 165 Bond, Lader (CR8) 1974; 47 Nelson (CR50) 1982 Bravo, Julio-Pieper, Forsythe (CR11) 2012; 12 Mannie, Harmer, Cowen (CR43) 2007; 164 Anderson (CR3) 1968; 9 Mayer (CR44) 2011; 12 Chan, Goodwin, Harmer (CR15) 2007; 37 Abou Hachem, Andersen, Barrangou (CR1) 2013; 31 Browning, Reid, Cowen (CR13) 2006; 21 Harmer, Bhagwagar, Perrett (CR35) 2003; 28 Schlotz, Yim, Zoccola (CR57) 2011; 23 Messaoudi, Lalonde, Violle (CR45) 2011; 105 Brenner, Moeller, Chey, Schoenfeld (CR12) 2009; 104 Pariante, Lightman (CR51) 2008; 31 Fehring, Schneider, Raviele (CR27) 2006; 35 Browning, Holmes, Harmer (CR14) 2010; 10 Forsythe, Kunze (CR29) 2013; 70 Beck, Ward, Mendelson (CR6) 1961; 4 Bravo, Forsythe, Chew (CR10) 2011; 108 Crumeyrolle-Arias, Jaglin, Bruneau (CR19) 2014; 42 Bradley, Mogg, Falla, Hamilton (CR9) 1998; 12 Harmer, Shelley, Cowen, Goodwin (CR36) 2004; 161 Godlewska, Norbury, Selvaraj (CR33) 2012; 42 Harmer, Goodwin, Cowen (CR37) 2009; 195 Mogg, Bradley (CR46) 1998; 36 Cryan, O’Mahony (CR21) 2011; 23 Koster, Crombez, Verschuere, De Houwer (CR39) 2004; 42 CR28 Bhagwagar, Cowen (CR7) 2007 Dinan, Quigley, Ahmed (CR23) 2006; 130 CR24 Lyte (CR42) 2011; 33 Koster, Verschuere, Crombez, Van Damme (CR40) 2005; 43 CR65 Eysenck, Eysenck (CR26) 1975 Watson, Clark, Tellegen (CR63) 1988; 54 Wolfram, Bellingrath, Kudielka (CR64) 2011; 36 CR62 Rao, Bested, Beaulne (CR54) 2009; 1 Kennedy, Clarke, Quigley (CR38) 2012; 36 Sudo, Chida, Aiba (CR60) 2004; 558 Mogg, Bradley, Hallowell (CR47) 1994; 47 N Anderson (3810_CR3) 1968; 9 BP Bradley (3810_CR9) 1998; 12 BR Godlewska (3810_CR33) 2012; 42 SE Murphy (3810_CR49) 2009; 12 H Nelson (3810_CR50) 1982 AT Beck (3810_CR6) 1961; 4 AT Beck (3810_CR5) 1997; 35 W Schlotz (3810_CR57) 2011; 23 YI Sheline (3810_CR58) 2001; 50 CJ Harmer (3810_CR35) 2003; 28 ZN Mannie (3810_CR43) 2007; 164 HM Savignac (3810_CR56) 2013; 63 K Tillisch (3810_CR61) 2013; 144 C Spielberger (3810_CR59) 1970 JC Pruessner (3810_CR53) 1997; 61 3810_CR28 EHW Koster (3810_CR39) 2004; 42 SH Rhee (3810_CR55) 2009; 6 EA Mayer (3810_CR44) 2011; 12 3810_CR65 M Wolfram (3810_CR64) 2011; 36 SWY Chan (3810_CR15) 2007; 37 3810_CR24 M Crumeyrolle-Arias (3810_CR19) 2014; 42 JF Cryan (3810_CR20) 2012; 13 TG Dinan (3810_CR22) 2012; 37 3810_CR62 AD Craig (3810_CR18) 2009; 10 Z Bhagwagar (3810_CR7) 2007 A Bond (3810_CR8) 1974; 47 CM Pariante (3810_CR51) 2008; 31 SR Kunz-Ebrecht (3810_CR41) 2004; 29 MG Gareau (3810_CR31) 2007; 56 AT Beck (3810_CR4) 2008; 165 S Cohen (3810_CR17) 1983; 24 H Eysenck (3810_CR26) 1975 M Abou Hachem (3810_CR1) 2013; 31 M Browning (3810_CR14) 2010; 10 CJ Harmer (3810_CR34) 2010; 27 JA Bravo (3810_CR11) 2012; 12 N Sudo (3810_CR60) 2004; 558 AV Rao (3810_CR54) 2009; 1 JM Cisler (3810_CR16) 2010; 30 MG Gareau (3810_CR32) 2010; 7 M Messaoudi (3810_CR45) 2011; 105 K Mogg (3810_CR47) 1994; 47 M Lyte (3810_CR42) 2011; 33 JF Cryan (3810_CR21) 2011; 23 DM Brenner (3810_CR12) 2009; 104 P Forsythe (3810_CR29) 2013; 70 SE Murphy (3810_CR48) 2009; 194 DA Pizzagalli (3810_CR52) 2010; 36 A Ait-Belgnaoui (3810_CR2) 2012; 37 D Watson (3810_CR63) 1988; 54 M Browning (3810_CR13) 2006; 21 CJ Harmer (3810_CR36) 2004; 161 TG Dinan (3810_CR23) 2006; 130 CHY Fu (3810_CR30) 2004; 61 JA Bravo (3810_CR10) 2011; 108 R Elliott (3810_CR25) 2011; 36 K Mogg (3810_CR46) 1998; 36 PJ Kennedy (3810_CR38) 2012; 36 RJ Fehring (3810_CR27) 2006; 35 CJ Harmer (3810_CR37) 2009; 195 EHW Koster (3810_CR40) 2005; 43 |
| References_xml | – volume: 33 start-page: 574 year: 2011 end-page: 581 ident: CR42 article-title: Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics publication-title: Bioessays doi: 10.1002/bies.201100024 – volume: 54 start-page: 1063 year: 1988 end-page: 1070 ident: CR63 article-title: Development and validation of brief measures of positive and negative affect: the Positive and Negative Affect Schedule scales publication-title: J Pers Soc Psychol doi: 10.1037/0022-3514.54.6.1063 – volume: 27 start-page: 231 year: 2010 end-page: 233 ident: CR34 article-title: Antidepressant drug action: a neuropsychological perspective publication-title: Depress Anxiety doi: 10.1002/da.20680 – volume: 165 start-page: 969 year: 2008 end-page: 977 ident: CR4 article-title: The evolution of the cognitive model of depression and its neurobiological correlates publication-title: Am J Psychiatr doi: 10.1176/appi.ajp.2008.08050721 – volume: 35 start-page: 49 year: 1997 end-page: 58 ident: CR5 article-title: An information processing model of anxiety: automatic and strategic processes publication-title: Behav Res Ther doi: 10.1016/S0005-7967(96)00069-1 – year: 1982 ident: CR50 publication-title: The National Adult Reading Test (NART): test manual – year: 1970 ident: CR59 publication-title: Manual for the State-Trait Anxiety Inventory (STAI) – volume: 12 start-page: 169 year: 2009 end-page: 179 ident: CR49 article-title: Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers publication-title: Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacologicum (CINP) – volume: 70 start-page: 55 year: 2013 end-page: 69 ident: CR29 article-title: Voices from within: gut microbes and the CNS publication-title: Cell Mol Life Sci doi: 10.1007/s00018-012-1028-z – volume: 47 start-page: 841 year: 1994 end-page: 864 ident: CR47 article-title: Attentional bias to threat: roles of trait anxiety, stressful events, and awareness publication-title: Q J Exp Psychol Sect A doi: 10.1080/14640749408401099 – volume: 144 start-page: 1394 year: 2013 end-page: 1401.e4 ident: CR61 article-title: Consumption of fermented milk product with probiotic modulates brain activity publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.02.043 – volume: 194 start-page: 535 year: 2009 end-page: 540 ident: CR48 article-title: Effect of a single dose of citalopram on amygdala response to emotional faces publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.108.056093 – volume: 23 start-page: 80 year: 2011 end-page: 94 ident: CR57 article-title: The perceived stress reactivity scale: measurement invariance, stability, and validity in three countries publication-title: Psychol Assess doi: 10.1037/a0021148 – volume: 37 start-page: 1369 year: 2012 end-page: 1378 ident: CR22 article-title: Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.03.007 – volume: 37 start-page: 1281 year: 2007 end-page: 1291 ident: CR15 article-title: Highly neurotic never-depressed students have negative biases in information processing publication-title: Psychol Med doi: 10.1017/S0033291707000669 – volume: 36 start-page: 905 issue: 6 year: 2011 end-page: 912 ident: CR64 article-title: The cortisol awakening response (CAR) across the female menstrual cycle publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2010.12.006 – year: 2007 ident: CR7 article-title: ‘It’s not over when it’s over’: persistent neurobiological abnormalities in recovered depressed patients publication-title: Psychol Med – volume: 56 start-page: 1522 year: 2007 end-page: 1528 ident: CR31 article-title: Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation publication-title: Gut doi: 10.1136/gut.2006.117176 – volume: 24 start-page: 385 year: 1983 end-page: 396 ident: CR17 article-title: A global measure of perceived stress publication-title: J Health Soc Behav doi: 10.2307/2136404 – volume: 42 start-page: 2609 year: 2012 end-page: 2617 ident: CR33 article-title: Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients publication-title: Psychol Med doi: 10.1017/S0033291712000591 – volume: 35 start-page: 376 issue: 3 year: 2006 end-page: 384 ident: CR27 article-title: Variability in the phases of the menstrual cycle publication-title: J Obstet Gynecol Neonat Nurs doi: 10.1111/j.1552-6909.2006.00051.x – volume: 61 start-page: 2539 year: 1997 end-page: 2549 ident: CR53 article-title: Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity publication-title: Life Sci doi: 10.1016/S0024-3205(97)01008-4 – volume: 6 start-page: 306 year: 2009 end-page: 314 ident: CR55 article-title: Principles and clinical implications of the brain–gut–enteric microbiota axis publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2009.35 – volume: 36 start-page: 183 year: 2010 end-page: 206 ident: CR52 article-title: Frontocingulate dysfunction in depression: toward biomarkers of treatment response publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.166 – volume: 104 start-page: 1033 year: 2009 end-page: 1049 ident: CR12 article-title: The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.25 – volume: 37 start-page: 1885 year: 2012 end-page: 1895 ident: CR2 article-title: Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.03.024 – volume: 30 start-page: 203 year: 2010 end-page: 216 ident: CR16 article-title: Mechanisms of attentional biases towards threat in anxiety disorders: an integrative review publication-title: Clin Psychol Rev doi: 10.1016/j.cpr.2009.11.003 – volume: 28 start-page: 148 year: 2003 end-page: 152 ident: CR35 article-title: Acute SSRI administration affects the processing of social cues in healthy volunteers publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300004 – volume: 50 start-page: 651 year: 2001 end-page: 658 ident: CR58 article-title: Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(01)01263-X – volume: 63 start-page: 756 year: 2013 end-page: 764 ident: CR56 article-title: Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine publication-title: Neurochem Int doi: 10.1016/j.neuint.2013.10.006 – volume: 9 start-page: 272 year: 1968 end-page: 279 ident: CR3 article-title: Likableness ratings of 555 personality trait words publication-title: J Pers Soc Psychol doi: 10.1037/h0025907 – volume: 12 start-page: 737 year: 1998 end-page: 753 ident: CR9 article-title: Attentional bias for threatening facial expressions in anxiety: manipulation of stimulus duration publication-title: Cogn Emot doi: 10.1080/026999398379411 – volume: 10 start-page: 8 year: 2010 end-page: 20 ident: CR14 article-title: The modification of attentional bias to emotional information: a review of the techniques, mechanisms, and relevance to emotional disorders publication-title: Cogn Affect Behav Neurosci doi: 10.3758/CABN.10.1.8 – volume: 105 start-page: 755 year: 2011 end-page: 764 ident: CR45 article-title: Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects publication-title: Br J Nutr doi: 10.1017/S0007114510004319 – volume: 36 start-page: 809 year: 1998 end-page: 848 ident: CR46 article-title: A cognitive-motivational analysis of anxiety publication-title: Behav Res Ther doi: 10.1016/S0005-7967(98)00063-1 – volume: 36 start-page: 153 year: 2011 end-page: 182 ident: CR25 article-title: Affective cognition and its disruption in mood disorders publication-title: Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol doi: 10.1038/npp.2010.77 – volume: 31 start-page: 464 year: 2008 end-page: 468 ident: CR51 article-title: The HPA axis in major depression: classical theories and new developments publication-title: Trends Neurosci doi: 10.1016/j.tins.2008.06.006 – volume: 13 start-page: 701 year: 2012 end-page: 712 ident: CR20 article-title: Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour publication-title: Nat Rev Neurosci doi: 10.1038/nrn3346 – volume: 23 start-page: 187 year: 2011 end-page: 192 ident: CR21 article-title: The microbiome-gut-brain axis: from bowel to behavior publication-title: Neurogastroenterol Motil doi: 10.1111/j.1365-2982.2010.01664.x – volume: 7 start-page: 503 year: 2010 end-page: 514 ident: CR32 article-title: Probiotics and the gut microbiota in intestinal health and disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2010.117 – volume: 36 start-page: 310 year: 2012 end-page: 340 ident: CR38 article-title: Gut memories: towards a cognitive neurobiology of irritable bowel syndrome publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2011.07.001 – volume: 43 start-page: 1087 year: 2005 end-page: 1098 ident: CR40 article-title: Time-course of attention for threatening pictures in high and low trait anxiety publication-title: Behav Res Ther doi: 10.1016/j.brat.2004.08.004 – volume: 164 start-page: 617 year: 2007 end-page: 621 ident: CR43 article-title: Increased waking salivary cortisol levels in young people at familial risk of depression publication-title: Am J Psychiatry doi: 10.1176/ajp.2007.164.4.617 – volume: 1 start-page: 6 year: 2009 ident: CR54 article-title: A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome publication-title: Gut Pathog doi: 10.1186/1757-4749-1-6 – volume: 195 start-page: 102 year: 2009 end-page: 108 ident: CR37 article-title: Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action publication-title: Br J Psychiatr J Ment Sci doi: 10.1192/bjp.bp.108.051193 – volume: 42 start-page: 1183 year: 2004 end-page: 1192 ident: CR39 article-title: Selective attention to threat in the dot probe paradigm: differentiating vigilance and difficulty to disengage publication-title: Behav Res Ther doi: 10.1016/j.brat.2003.08.001 – volume: 42 start-page: 207 year: 2014 end-page: 217 ident: CR19 article-title: Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2014.01.014 – volume: 108 start-page: 16050 year: 2011 end-page: 16055 ident: CR10 article-title: Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1102999108 – volume: 12 start-page: 453 year: 2011 end-page: 466 ident: CR44 article-title: Gut feelings: the emerging biology of gut–brain communication publication-title: Nat Rev Neurosci doi: 10.1038/nrn3071 – volume: 130 start-page: 304 year: 2006 end-page: 311 ident: CR23 article-title: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.033 – volume: 61 start-page: 877 year: 2004 end-page: 889 ident: CR30 article-title: Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.9.877 – volume: 558 start-page: 263 year: 2004 end-page: 275 ident: CR60 article-title: Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice publication-title: J Physiol doi: 10.1113/jphysiol.2004.063388 – year: 1975 ident: CR26 publication-title: Manual of the Eysenck personality questionnaire – ident: CR65 – volume: 12 start-page: 667 issue: 6 year: 2012 end-page: 672 ident: CR11 article-title: Communication between gastrointestinal bacteria and the nervous system publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2012.09.010 – volume: 161 start-page: 1256 year: 2004 end-page: 1263 ident: CR36 article-title: Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition publication-title: Am J Psychiatr doi: 10.1176/appi.ajp.161.7.1256 – volume: 21 start-page: 684 year: 2006 end-page: 690 ident: CR13 article-title: A single dose of citalopram increases fear recognition in healthy subjects publication-title: J Psychopharmacol doi: 10.1177/0269881106074062 – volume: 29 start-page: 516 year: 2004 end-page: 528 ident: CR41 article-title: Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort publication-title: Psychoneuroendocrinology doi: 10.1016/S0306-4530(03)00072-6 – volume: 31 start-page: 226 year: 2013 end-page: 235 ident: CR1 article-title: Recent insight into oligosaccharide uptake and metabolism in probiotic bacteria publication-title: Biocatal Biotransform doi: 10.3109/10242422.2013.828048 – volume: 47 start-page: 211 year: 1974 end-page: 218 ident: CR8 article-title: The use of analogue scales in rating subjective feelings publication-title: Br J Med Psychol doi: 10.1111/j.2044-8341.1974.tb02285.x – volume: 4 start-page: 561 year: 1961 end-page: 571 ident: CR6 article-title: An inventory for measuring depression publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1961.01710120031004 – ident: CR28 – ident: CR62 – volume: 10 start-page: 59 year: 2009 end-page: 70 ident: CR18 article-title: How do you feel—now? The anterior insula and human awareness publication-title: Nat Rev Neurosci doi: 10.1038/nrn2555 – ident: CR24 – volume: 36 start-page: 905 issue: 6 year: 2011 ident: 3810_CR64 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2010.12.006 – volume: 558 start-page: 263 year: 2004 ident: 3810_CR60 publication-title: J Physiol doi: 10.1113/jphysiol.2004.063388 – ident: 3810_CR24 – volume: 35 start-page: 376 issue: 3 year: 2006 ident: 3810_CR27 publication-title: J Obstet Gynecol Neonat Nurs doi: 10.1111/j.1552-6909.2006.00051.x – volume: 161 start-page: 1256 year: 2004 ident: 3810_CR36 publication-title: Am J Psychiatr doi: 10.1176/appi.ajp.161.7.1256 – ident: 3810_CR28 – volume: 50 start-page: 651 year: 2001 ident: 3810_CR58 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(01)01263-X – volume: 21 start-page: 684 year: 2006 ident: 3810_CR13 publication-title: J Psychopharmacol doi: 10.1177/0269881106074062 – volume: 164 start-page: 617 year: 2007 ident: 3810_CR43 publication-title: Am J Psychiatry doi: 10.1176/ajp.2007.164.4.617 – volume: 194 start-page: 535 year: 2009 ident: 3810_CR48 publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.108.056093 – volume: 1 start-page: 6 year: 2009 ident: 3810_CR54 publication-title: Gut Pathog doi: 10.1186/1757-4749-1-6 – volume-title: Manual of the Eysenck personality questionnaire year: 1975 ident: 3810_CR26 – volume: 36 start-page: 310 year: 2012 ident: 3810_CR38 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2011.07.001 – volume: 42 start-page: 207 year: 2014 ident: 3810_CR19 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2014.01.014 – volume: 36 start-page: 153 year: 2011 ident: 3810_CR25 publication-title: Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol doi: 10.1038/npp.2010.77 – volume: 144 start-page: 1394 year: 2013 ident: 3810_CR61 publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.02.043 – volume: 31 start-page: 226 year: 2013 ident: 3810_CR1 publication-title: Biocatal Biotransform doi: 10.3109/10242422.2013.828048 – volume: 9 start-page: 272 year: 1968 ident: 3810_CR3 publication-title: J Pers Soc Psychol doi: 10.1037/h0025907 – volume: 23 start-page: 80 year: 2011 ident: 3810_CR57 publication-title: Psychol Assess doi: 10.1037/a0021148 – volume: 47 start-page: 841 year: 1994 ident: 3810_CR47 publication-title: Q J Exp Psychol Sect A doi: 10.1080/14640749408401099 – volume: 61 start-page: 2539 year: 1997 ident: 3810_CR53 publication-title: Life Sci doi: 10.1016/S0024-3205(97)01008-4 – volume: 4 start-page: 561 year: 1961 ident: 3810_CR6 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1961.01710120031004 – ident: 3810_CR62 doi: 10.3945/ajcn.2008.26242 – volume: 47 start-page: 211 year: 1974 ident: 3810_CR8 publication-title: Br J Med Psychol doi: 10.1111/j.2044-8341.1974.tb02285.x – volume: 61 start-page: 877 year: 2004 ident: 3810_CR30 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.9.877 – volume: 105 start-page: 755 year: 2011 ident: 3810_CR45 publication-title: Br J Nutr doi: 10.1017/S0007114510004319 – volume: 195 start-page: 102 year: 2009 ident: 3810_CR37 publication-title: Br J Psychiatr J Ment Sci doi: 10.1192/bjp.bp.108.051193 – volume: 28 start-page: 148 year: 2003 ident: 3810_CR35 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300004 – volume: 108 start-page: 16050 year: 2011 ident: 3810_CR10 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1102999108 – volume: 36 start-page: 809 year: 1998 ident: 3810_CR46 publication-title: Behav Res Ther doi: 10.1016/S0005-7967(98)00063-1 – volume: 31 start-page: 464 year: 2008 ident: 3810_CR51 publication-title: Trends Neurosci doi: 10.1016/j.tins.2008.06.006 – volume: 30 start-page: 203 year: 2010 ident: 3810_CR16 publication-title: Clin Psychol Rev doi: 10.1016/j.cpr.2009.11.003 – volume: 165 start-page: 969 year: 2008 ident: 3810_CR4 publication-title: Am J Psychiatr doi: 10.1176/appi.ajp.2008.08050721 – volume: 56 start-page: 1522 year: 2007 ident: 3810_CR31 publication-title: Gut doi: 10.1136/gut.2006.117176 – volume: 23 start-page: 187 year: 2011 ident: 3810_CR21 publication-title: Neurogastroenterol Motil doi: 10.1111/j.1365-2982.2010.01664.x – volume: 24 start-page: 385 year: 1983 ident: 3810_CR17 publication-title: J Health Soc Behav doi: 10.2307/2136404 – volume: 35 start-page: 49 year: 1997 ident: 3810_CR5 publication-title: Behav Res Ther doi: 10.1016/S0005-7967(96)00069-1 – volume: 36 start-page: 183 year: 2010 ident: 3810_CR52 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.166 – volume: 42 start-page: 1183 year: 2004 ident: 3810_CR39 publication-title: Behav Res Ther doi: 10.1016/j.brat.2003.08.001 – volume: 27 start-page: 231 year: 2010 ident: 3810_CR34 publication-title: Depress Anxiety doi: 10.1002/da.20680 – volume: 12 start-page: 169 year: 2009 ident: 3810_CR49 publication-title: Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacologicum (CINP) – volume: 10 start-page: 59 year: 2009 ident: 3810_CR18 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2555 – volume: 12 start-page: 737 year: 1998 ident: 3810_CR9 publication-title: Cogn Emot doi: 10.1080/026999398379411 – volume: 33 start-page: 574 year: 2011 ident: 3810_CR42 publication-title: Bioessays doi: 10.1002/bies.201100024 – volume: 63 start-page: 756 year: 2013 ident: 3810_CR56 publication-title: Neurochem Int doi: 10.1016/j.neuint.2013.10.006 – volume: 54 start-page: 1063 year: 1988 ident: 3810_CR63 publication-title: J Pers Soc Psychol doi: 10.1037/0022-3514.54.6.1063 – year: 2007 ident: 3810_CR7 publication-title: Psychol Med – volume: 12 start-page: 667 issue: 6 year: 2012 ident: 3810_CR11 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2012.09.010 – volume: 37 start-page: 1281 year: 2007 ident: 3810_CR15 publication-title: Psychol Med doi: 10.1017/S0033291707000669 – volume-title: The National Adult Reading Test (NART): test manual year: 1982 ident: 3810_CR50 – volume: 104 start-page: 1033 year: 2009 ident: 3810_CR12 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.25 – volume: 37 start-page: 1369 year: 2012 ident: 3810_CR22 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.03.007 – volume: 43 start-page: 1087 year: 2005 ident: 3810_CR40 publication-title: Behav Res Ther doi: 10.1016/j.brat.2004.08.004 – volume-title: Manual for the State-Trait Anxiety Inventory (STAI) year: 1970 ident: 3810_CR59 – ident: 3810_CR65 doi: 10.1016/S0010-0277(97)00003-6 – volume: 13 start-page: 701 year: 2012 ident: 3810_CR20 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3346 – volume: 130 start-page: 304 year: 2006 ident: 3810_CR23 publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.033 – volume: 7 start-page: 503 year: 2010 ident: 3810_CR32 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2010.117 – volume: 37 start-page: 1885 year: 2012 ident: 3810_CR2 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.03.024 – volume: 6 start-page: 306 year: 2009 ident: 3810_CR55 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2009.35 – volume: 70 start-page: 55 year: 2013 ident: 3810_CR29 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-012-1028-z – volume: 12 start-page: 453 year: 2011 ident: 3810_CR44 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3071 – volume: 29 start-page: 516 year: 2004 ident: 3810_CR41 publication-title: Psychoneuroendocrinology doi: 10.1016/S0306-4530(03)00072-6 – volume: 42 start-page: 2609 year: 2012 ident: 3810_CR33 publication-title: Psychol Med doi: 10.1017/S0033291712000591 – volume: 10 start-page: 8 year: 2010 ident: 3810_CR14 publication-title: Cogn Affect Behav Neurosci doi: 10.3758/CABN.10.1.8 |
| SSID | ssj0000484 ssj0068394 |
| Score | 2.6071303 |
| Snippet | Rationale
There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of... There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of information... Rationale There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of... Rationale: There is now compelling evidence for a link between enteric microbiota and brain function. The ingestion of probiotics modulates the processing of... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1793 |
| SubjectTerms | Adolescent Adult Animals Anxiety Biomedical and Life Sciences Biomedicine Dietary fiber Dietary Supplements Digestive system Double-Blind Method Emotions Emotions - physiology Female Healthy Volunteers Hormones Humans Hydrocortisone Hydrocortisone - metabolism Male Microbiology Middle Aged Neurosciences Oligosaccharides - administration & dosage Original Investigation Pharmacology/Toxicology Photic Stimulation - methods Physiological aspects Prebiotics - administration & dosage Probiotics Psychiatry Psychological aspects Psychopharmacology Rats Saliva - metabolism Wakefulness - physiology Young Adult |
| SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA9SQXwRrV-rVSJIBe3ifiTZ5LEcliJU7qGFvoXNFy7Kntxukfvvncnu7XUPLfh4zCTkdibJb8jMbwh5L2QRJBg79YUrIECxLDW5cmnmnMh9KVwZKYUuvonzK_b1ml-PZNFYC7P3fv85dk3CjB-WIhdVCtH5fZ6XFXZpWIjF7tBlWG85_BBw6Q_syyXWjnG5fc3823yz-2j_VL51Le2nTO69m8br6OwxeTTiSHo6GP4JuefbQ_LgYnwpPyTHy4GTenNCL3clVt0JPabLHVv15inxy7U3zQqEtGn7-oena2Rz9R0FaEh_x2ZVFELUvgEvBVlMqfW0bh2NL-0d9UMnIFiNaeoOZqFDceWG4tEHhgOlZ-Tq7Mvl4jwdey-ktspEnxruDbNMMM-cdeBulTMhE5myMvNcGiWN5cp5QExWBJWVNgQLWAoAhnIuN-VzctCuWv-S0Io7mTNXmiANhGPB1CEEwA21564IJiQk21pA25GYHPtj_NQTpXI0mgajaTSazhLycRrya2DluEv5A5pV446FeW09Fh7A6pD7Sp-ykuHJVeQJOZppwk6zc_HWMfS40zudY8QFGJmphLybxDgSs9dav7qJOoIrAcHbXToSuwEAdkjIi8HXpr-GNHJKKBhdzbxwUkCO8Lmkbb5HrnBAu8jKl5BPW3-9tfR_fbFX_6X9mjwEFMmHLNAjctCvb_wbQGq9eRv36B8YYjR3 priority: 102 providerName: Springer Nature |
| Title | Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers |
| URI | https://link.springer.com/article/10.1007/s00213-014-3810-0 https://www.ncbi.nlm.nih.gov/pubmed/25449699 https://www.proquest.com/docview/1675831049 https://www.proquest.com/docview/1676596559 https://www.proquest.com/docview/1680436678 https://pubmed.ncbi.nlm.nih.gov/PMC4410136 |
| Volume | 232 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ri9NAEF_0DsQvoucreh4ryAl6wTw2m-STtKX1UK4UuUL9FLIvDEp6Njmk_70zm0cvBfulocxs2GRmZ3-bnf0NIe94EpgEjO3qQAWwQJHMFX6qXE8p7uuQq9BSCl3N-eWSfV1Fq_aDW9WmVXYx0QZqtZb4jfyTj8gWsAhLP9_8cbFqFO6utiU07pNjpC5Dr45X8S4SMzyE2fzhgAQaSuYQD5RFSbfF6VlG0QCLHPjMRcIr1xtMUvuh-s5ctZ9HubeZaueo2WPyqAWXdNR4wxNyT5cn5MFVu31-Qs4XDVH19oJe785dVRf0nC52FNbbp0QvNloUaxDSoqzzX5pukOJVVxTwIv1rK1hRWLfWBbguyGyeraZ5qajdfq-obsoDQW9EkVdwF9qcuNxSjIdgTVB6Rpaz6fXk0m0LMrgy9njtikgLJhlnmimpwAdjJYzHvVQmno4SkSZCRqnSAKMkN6kXSmMkACxAHalSvgifk6NyXeqXhMaRSnymQmESAWs0I3JjDICJXEcqMMI4xOsskMmWrRyLZvzOep5la7QMjJah0TLPIR_6JjcNVcch5fdo1gyHMdxX5u1pBOgdEmJlIxYyDGeB75DTgSYMPzkUd46RtcO_ynbO6pC3vRhbYkpbqde3VodHKYcV3SGdBEsEAKBwyIvG1_pHQ265lKfQOh54Ya-AxOFDSVn8tATiAIGRqs8hHzt_vdP1_72xV4cf9DV5CFgyanJBT8lRvbnVbwCv1eLMDsozcjyajcdzvH758W0K1_F0vvgO0gmfwO8yGP0DKZZCtg |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgEXBOVlKLBIUCSoxdper-0DQhVQpbSpckil3FzvS0Qgp8SpqvwpfiMzfiRNJHLrMdrZle2Znfkmu_MNwFuZhi5FZfs2NCEmKFr4KsiMz42RgY2kiWpKof6p7J2JH6N4tAV_u1oYulbZ-cTaUZuJpv_IPwWEbBGLiOzLxR-fukbR6WrXQqMxi2M7v8KUrfp89A31-y4MD78Pv_b8tquArxMuZ76KrRJaSGGF0QY_ZGKU45JnOuU2TlWWKh1nxiIW0NJlPNLOaUQJGDozYwIV4bq34DYGXk7JXjJKlp5fUNFn80Mi8mgooCMqYIvT7kiV1wymITVVCIRPBFs-XwmK66HhWmxcv7e5dnhbx8TDB3C_BbPsoLG-h7Blyx2402-P63dgb9AQY8_32XBZ51Xtsz02WFJmzx-BHUytGk9wkI3LWfHLsilRytqKIT5lV3XHLIZ58myMWwXH6nu9lhWlYfVxf8Vs044In0aNiwpXYU2F55yR_0XrQaHHcHYjqnoC2-WktM-AJbFJA2Ei5VKFOaFThXMOwUthYxM65TzgnQZy3bKjU5OO3_mC17lWWo5Ky0lpOffgw2LKRUMNskn4Pak1J7eB6-qirX7ApyMCrvxARILcZxh4sLsiidtdrw53hpG37qbKl5vDgzeLYZpJV-hKO7msZWScScwgN8mk1JIAAYwHTxtbW7wacdllMsPZyYoVLgSIqHx1pBz_rAnLEXITNaAHHzt7vfbo__tizze_6Gu42xv2T_KTo9PjF3APcWzc3EPdhe3Z9NK-RKw4U6_qDcrg_KY9wj-UT3tV |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEB6VVKp4QVAulwKLBEWCWvWxXtsPCBXaqKU0ilAr9c14LxEVOSVOVeWv8euY8ZUmEnnrY7SHbM_szDfZmW8A3ooksAkK2zWBDjBAUdyVfqpdT2vhm1DosKIUOh2Io3P-7SK6WIO_bS0MpVW2NrEy1Hqs6D_yPZ-QLWIRnu7ZJi1ieND_fPXHpQ5SdNPattOoVeTEzG4wfCs_HR-grN8FQf_w7OuR23QYcFXsiakrIyO54oIbrpXGjxpraT3hpSrxTJTINJEqSrVBXKCETb1QWasQMaAbTbX2ZYj73oP1mKKiHqx_ORwMf8z9AKcS0PqHQBxSE0KHVM4WJe0Fq1fxmQbUYsHnLtFtud6Ci1x2FLc85XIW59JVbuUh-w_hQQNt2X6ti49gzRSbsHHaXN5vws6wpsme7bKzedVXuct22HBOoD17DGY4MXI0xkE2Kqb5pWETIpg1JUO0ym6q_lkMo-bpCA8OjlVZvoblhWbV5X_JTN2cCJ9GjvISd2F1veeMkTVGXcJJT-D8ToT1FHrFuDDPgcWRTnyuQ2kTiRGilbm1FqFMbiIdWGkd8FoJZKrhSqeWHb-zjuW5ElqGQstIaJnnwIduyVVNFLJq8nsSa0ZGBPdVeVMLgU9HdFzZPg85GdPAd2B7YSYefrU43CpG1hifMpsfFQfedMO0khLqCjO-ruaIKBUYT66ak1CDAoQzDjyrda17NWK2S0WKq-MFLewmEG354kgx-lXRlyMAJ6JABz62-nrr0f_3xbZWv-hr2EBrkH0_Hpy8gPsIaqM6KXUbetPJtXmJwHEqXzUnlMHPuzYK_wDP-oDw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prebiotic+intake+reduces+the+waking+cortisol+response+and+alters+emotional+bias+in+healthy+volunteers&rft.jtitle=Psychopharmacology&rft.au=Schmidt%2C+Kristin&rft.au=Cowen%2C+Philip+J.&rft.au=Harmer%2C+Catherine+J.&rft.au=Tzortzis%2C+George&rft.date=2015-05-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=232&rft.issue=10&rft.spage=1793&rft.epage=1801&rft_id=info:doi/10.1007%2Fs00213-014-3810-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00213_014_3810_0 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |